Coherus Oncology (CHRS) Stock Price & Financial Analysis
Coherus Oncology Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Coherus Oncology
What is the current stock price for CHRS?
As of the latest trading session, CHRS stock trades at $1.37. The 52-week range is $1.09–$2.62, with a day range of $1.36–$1.43.
What is the P/E ratio for CHRS?
Coherus Oncology's trailing P/E ratio is 1.0, meaning investors pay $1.0 for every $1 of annual earnings. Coherus Oncology operates in the Healthcare sector.
Does CHRS pay dividends?
Coherus Oncology does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for CHRS?
Based on 1 analyst, the consensus for CHRS is Buy.
What is the market cap of CHRS?
Coherus Oncology's market capitalization is $186.9M, classifying it as a micro-cap company. Coherus Oncology operates in the Healthcare sector within the Biotechnology industry.